WallStreetZenWallStreetZen

NASDAQ: GLMD
Galmed Pharmaceuticals Ltd Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

GLMD past revenue growth

How has GLMD's revenue growth performed historically?
Company
N/A
Industry
145.73%
Market
17.2%
GLMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
GLMD's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

GLMD earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$6.9M
Current Profit Margin
0%

GLMD Return on Equity

Current Company
-53.3%
Current Industry
-63.5%
Current Market
188%
GLMD's Return on Equity (-53.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when GLMD announces earnings.

GLMD Return on Assets

Current Company
-44.4%
Current Industry
2.9%
GLMD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

GLMD Return on Capital Employed

Current Company
-53.98%
Current Industry
19.5%
GLMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

GLMD vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
GLMD$0.00-$7.46M-$6.91M-100.00%N/A
SCNI$0.00N/A-$10.95MN/AN/A
QLGN$0.00-$11.89M-$13.42M-100.00%N/A
CYCC$420.00k-$25.52M-$22.76M+22.87%N/A
SLRX$0.00-$12.53M-$12.54M-100.00%N/A
View Top Biotech Stocks

GLMD earnings dates

Next earnings date
May 30, 2024

Galmed Pharmaceuticals Earnings & Revenue FAQ

What were GLMD's earnings last quarter?

On Invalid Date, Galmed Pharmaceuticals (NASDAQ: GLMD) reported Q4 2023 earnings per share (EPS) of -$0.98, up 34.67% year over year. Total Galmed Pharmaceuticals earnings for the quarter were -$2.02 million. In the same quarter last year, Galmed Pharmaceuticals's earnings per share (EPS) was -$1.50.

If you're new to stock investing, here's how to buy Galmed Pharmaceuticals stock.

What was GLMD's earnings growth in the past year?

As of Q2 2024, Galmed Pharmaceuticals's earnings has grown year over year. Galmed Pharmaceuticals's earnings in the past year totalled -$6.91 million.

What is GLMD's earnings date?

Galmed Pharmaceuticals's earnings date is Invalid Date. Add GLMD to your watchlist to be reminded of GLMD's next earnings announcement.

What was GLMD's revenue last quarter?

On Invalid Date, Galmed Pharmaceuticals (NASDAQ: GLMD) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Galmed Pharmaceuticals's revenue was $0.00.

What was GLMD's revenue growth in the past year?

As of Q2 2024, Galmed Pharmaceuticals's revenue has grown null year over year. Galmed Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.